Hyster-Yale, Inc. filed an 8-K on November 18, 2026, disclosing its intention to offer $125,000,000 aggregate principal amount of convertible senior notes due 2031 in a private placement to qualified institutional buyers under Rule 144A.
Key Highlights
- Offering size: $125,000,000 aggregate principal amount of convertible senior notes due November 15, 2031, with an overallotment option for up to an additional $18,750,000.
- Term loan repayment: Hyster-Yale intends to use proceeds to repay $100.0 million of the $213.2 million principal amount outstanding under its 2021 Credit Agreement term loan.
- Concurrent share repurchase: Up to $15 million of net proceeds are intended to repurchase shares of Class A common stock concurrently with pricing, in privately negotiated transactions.
- Capped call transactions: Hyster-Yale expects to enter into capped call transactions designed to reduce potential dilution to Class A common stock upon conversion of the notes.
- Settlement mechanics: Conversions will be settled in cash up to the principal amount converted, with any remainder settled in cash, Class A common stock, or a combination, at Hyster-Yale's election.
- Private placement only: The notes are offered solely to qualified institutional buyers under Rule 144A and have not been registered under the Securities Act of 1933.
Hyster-Yale's $125 Million Convertible Note Terms and Intended Use of Proceeds
According to the filing, Hyster-Yale, Inc. (NYSE:HY) announced its intention to offer $125,000,000 aggregate principal amount of convertible senior notes due 2031 in a private offering. The company disclosed that it also expects to grant initial purchasers an option to purchase up to an additional $18,750,000 aggregate principal amount of notes, exercisable for settlement within a period of 13 days from, and including, the date the notes are first issued. The interest rate, initial conversion rate, and other terms are to be determined at the time of pricing.
The filing states that the notes will be general senior unsecured obligations of Hyster-Yale, will accrue interest payable semi-annually in arrears, and will mature on November 15, 2031, unless earlier repurchased, redeemed, or converted. The company disclosed that the primary uses of net proceeds are: repayment of $100.0 million of the $213.2 million outstanding under the term loan under its Amended and Restated Term Loan Credit Agreement dated May 28, 2021; repurchase of up to $15 million of Class A common stock concurrently with pricing; payment of costs for capped call transactions; and general corporate purposes. The company stated it intends to repay the remaining term loan principal on or prior to its maturity with additional long-term debt on terms acceptable to the company.
Regarding the capped call transactions, the filing states that they "are generally expected to reduce the potential dilution to the Class A common stock upon any conversion of the notes and/or offset any potential cash payments HysterYale is required to make in excess of the principal amount of such converted notes." The filing also cautions that hedging activity by option counterparties could affect the market price of Class A common stock and the notes, and could affect the number of shares noteholders receive upon conversion. The filing contains forward-looking statements subject to the company's cautionary language regarding risks including supply chain disruptions, tariff impacts, and demand fluctuations.
What Was Disclosed
Hyster-Yale disclosed a proposed $125 million Rule 144A convertible senior notes offering due 2031, with proceeds intended primarily to partially repay its existing term loan, repurchase up to $15 million of Class A common stock, and fund capped call transactions.



Please wait processing your request...